Bondi, E., Obino, G., Guidotti, G., Sensini, A., Nagy, M., Spronk, H. M. H., van Griensven, M., Lepedda, A. J., Lotti, N., & Moroni, L. (2026). Aromatic Copolyesters Based on Poly(butylene furanoate) and Poly(butylene isophthalate) for Small-Diameter Vascular Applications. ACS Biomaterial Science and Engineering, 12(7), 3557-3568. https://doi.org/10.1021/acsbiomaterials.6c00106

Stroobants, A. K., Gottgens, E.-L., Henskens, Y. M. C., Jansen, J. H., Schols, S. E. M., & Rijpma, S. R. (2026). Monitoring Extended Half-Life Factor VIII and IX Concentrates: Performance in Routine Clotting-and Thrombin Generation Assays. Haemophilia, 32(4), 1002-1015. https://doi.org/10.1111/hae.70300

van Dam, A. D., Bioch, M. M., Jeninga, E. H., de Kok, J. B., Rijpma, S. R., Thelen, M. H. M., Henskens, Y. M. C., van Oerle, R. G. M., Stroobants, A. K., & Coagulation Section of the Dutch Foundation for Quality Assessment in Medical Laboratory Diagnostics (SKML) (2026). Pre-analytical storage and reagent-dependent sensitivity as sources of variability in prothrombin time and activated partial thromboplastin time measurements. Thrombosis Research, 263, Article 109771. https://doi.org/10.1016/j.thromres.2026.109771

Erdoes, G., Koster, A., Shore-Lesserson, L., Vilnits, Y., Steiner, M. E., ten Cate, H., & Mazzeffi, M. (2026). The Year in Coagulation and Transfusion: Selected Highlights. Journal of Cardiothoracic and Vascular Anesthesia, 40(7), 1939-1945. https://doi.org/10.1053/j.jvca.2026.03.005

Rocca, B., & ten Cate, H. (2026). Antidotes for Anticoagulation Reversal. New England Journal of Medicine, 394(22), 2235-2254. https://doi.org/10.1056/NEJMra2506021

Schellens, J., Nagy, M., Hulshof, A. M., van Rosmalen, F., van Oerle, R., van Herpt, T. T. W., Alnima, T., Mulder, M. M. G., Hellenbrand, D., ten Cate, H., Driessen, R. G. H., Sels, J. W. E. M., van der Horst, I. C. C., Henskens, Y. M. C., van Bussel, B. C. T., Spronk, H. M. H., & Dutch Covid and Thrombosis Coalition (2026). Inhibition of inflammation reduces hypofibrinolysis in severe COVID-19: A nested case-control study within the MaastrICCht cohort. Thrombosis Research, 262, Article 109723. https://doi.org/10.1016/j.thromres.2026.109723

Hamulyák, E. N., Wang, T. F., Kreuziger, L. B., Iyengar, V., Carney, B. J., Hoeben, A., Özdemir, B. C., Cordova Serrano, R. D., Sanfilippo, K. M., Rozenblatt, S., Beenen, L. F. M., Yust-Katz, S., Halperin, E., Arad, A., Lubetsky, A., Carrier, M., Massat, B., Büller, H. R., Spectre, G., ... ABC Study Group (2026). Intracranial hemorrhage in patients with primary brain cancer receiving anticoagulation. Blood Vessels, Thrombosis & Hemostasis, 3(2), Article 100140. https://doi.org/10.1016/j.bvth.2026.100140

Urlings, E. H., Heubel-Moenen, F. C. J. I., van Oerle, R., Hellenbrand, D. L. S., van der Meijden, P. E. J., Hackeng, T. M., Cate, H. T., Nagy, M., Henskens, Y. M. C., & Spronk, H. M. H. (2026). Intrinsic activated thrombin generation for treatment efficacy and monitoring of octocog alfa and emicizumab in severe hemophilia A. Research and practice in thrombosis and haemostasis, 10(4), Article 106627. https://doi.org/10.1016/j.rpth.2026.106627

Shaw, J. R., Maier, C. L., Hardy, M., Mullier, F., Douxfils, J., Tanaka, K., Rocca, B., ten Cate, H., Kim, P. Y., Carrier, M., Connors, J. M., & Levy, J. H. (2026). Thrombin generation and the pharmacodynamics of parenteral anticoagulants. Pharmacological Reviews, 78(3), Article 100135. https://doi.org/10.1016/j.pharmr.2026.100135

Abels, S., Sihvo, M., Tomppo, L., Kutal, S., Martinez-Majander, N., Tulkki, L., Sarkanen, T., Jakala, P., Redfors, P., Huhtakangas, J., Ylikotila, P., von Sarnowski, B., Yesilot, N., Waje-Andreassen, U., Fonseca, A. C., Martinez Sanchez, P., Korv, J., Ferdinand, P., Ryliskiene, K., ... Putaala, J. (2026). Thrombophilia Screening in Young Patients With Cryptogenic Ischemic Stroke. Stroke, 57(5), 1242-1255. https://doi.org/10.1161/STROKEAHA.125.053251

Franssen, I. S., Jong, M. J. D., Vievermans, A., Stroo, J. F., Henskens, Y. M. C., Spronk, H., Janssen, D. J. A., Braeken, D., van Kuijk, S. M. J., Winckers, K., & Magdelijns, F. J. H. (2026). Adequacy of Direct Oral Anticoagulant Dosing in Nursing Home Residents: Cross-Sectional Data From the DOAC-FRAIL Study. Journal of the American Medical Directors Association, 27(4), Article 106082. https://doi.org/10.1016/j.jamda.2025.106082

Aarts, A., Brandts, L., Pavlicic, M., Cate, H. T., & ten Cate-Hoek, A. J. (2026). Apixaban vs vitamin K antagonists in relation to postthrombotic syndrome: data from a prospective cohort study. Journal of Thrombosis and Haemostasis, 24(4), 1388-1396. https://doi.org/10.1016/j.jtha.2025.11.022

van Ginkel, D. J., Stragier, H., Bor, W. L., Rosseel, L., Konings, J., Ninivaggi, M., de Simone, I., Huskens, D., Roest, M., van Lenthe, I., Overduin, D. C., Aarnink, E. W., Rooijakkers, M. J. P., Peper, J., Brouwer, J., Nijenhuis, V. J., Rensing, B. J. W. M., Timmers, L., Swaans, M. J., ... ten Berg, J. M. (2026). Effects of continuation versus interruption of oral anticoagulation during transcatheter aortic valve implantation on hemostasis function. Journal of Thrombosis and Haemostasis, 24(4), 1263-1278. https://doi.org/10.1016/j.jtha.2025.11.005

ten Cate, H., & ten Berg, J. (2026). Fibrin clot lysis predicts anticoagulant-associated bleeding in atrial fibrillation: ready for clinical use?European Heart Journal, 47(16), 1961-1963. Article ehaf458. https://doi.org/10.1093/eurheartj/ehaf458

Willems, R. A. L., van Diepen, A. E., Dekker, E. N., Janssen, Q. P., van Dam, J. L., Michiels, N., van Eijck, C. W. F., Hermans, K. E. P. E., Bonsing, B. A., Bosscha, K. P., Bouwense, S. A. W., Busch, O. R., ten Cate, H., Coene, P.-P. L. O., van Eijck, C. H. J., van Es, N., van der Harst, E., de Hingh, I. H. J. T., Karsten, T. M., ... Dutch Pancreatic Canc Grp (2026). Thromboembolic Events During Perioperative Therapy for Resectable and Borderline Resectable Pancreatic Cancer in the PREOPANC-2 Trial. Journal of Clinical Oncology, 44(8), 662-675. https://doi.org/10.1200/JCO-25-01935

Jmel, M. A., Wu, H., Baaten, C. C. F. M. J., Xu, X., Nandakumar, K. S., & Kotsyfakis, M. (2026). Immunomodulatory Effects of a Tick Salivary Serpin on Psoriasis-like Inflammation. Life, 16(3), Article 427. https://doi.org/10.3390/life16030427

Krommenhoek, J. F., Beekman, W., Kor, F., Gal, P., Berkhout, W. E. M., Meijer, K., Braeken, D. C. W., Klok, F. A., ten Cate, H., & Olie, R. H. (2026). Andexanet alfa for the reversal of anticoagulation: Dutch practice data. Research and practice in thrombosis and haemostasis, 10(3), Article e103438. https://doi.org/10.1016/j.rpth.2026.103438

Aarts, A., ten Cate, H., & ten Cate-Hoek, A. J. (2026). Anticoagulants beyond coagulation: a narrative review of cardiovascular effects. Cardiovascular Research, 122(5), 562-577. https://doi.org/10.1093/cvr/cvag043

Sihvo, M. C., Ylikotila, P., Zedde, M., Pascarella, R., Sarkanen, T., Jatužis, D., Ryliškiene, K., von Sarnowski, B., Licenik, R., Ferdinand, P., Kõrv, J., Kõrv, L., Pezzini, A., Fonseca, A. C., Paula, A., Martínez-Sánchez, P., Yesilot, N., Fromm, A., Waje-Andreassen, U., ... Tomppo, L. (2026). Family history of stroke and cardiovascular diseases in early-onset cryptogenic ischaemic stroke. European Stroke Journal, 11(3), Article aakag013. https://doi.org/10.1093/esj/aakag013

Kempers, E. K., Visser, C., Seelig, J., Chen, Q., Adriaansen, H. J., Beinema, M. J., ten Cate-Hoek, A. J., Faber, L. M., Dronkers, C. E. A., Nierman, M. C., Schindhelm, R. K., Wiersma, N. M., Stork, A. D. M., Klok, F. A., Leebeek, F. W. G., Pisters, R., Cannegieter, S. C., De Caterina, R., Hemels, M. E. W., ... Kruip, M. J. H. A. (2026). Sex differences in outcomes of vitamin K antagonist treatment in patients with a mechanical heart valve: a Dutch population-based cohort study. Journal of Thrombosis and Haemostasis, 24(3), 955-970. https://doi.org/10.1016/j.jtha.2025.09.010

ten Cate, V., Sulochana, H. R., ten Cate, H., & Nagy, M. (2026). Coagulation factor XI and cardiovascular disease: A complex, cardio-specific conundrum. Med, 7(2), Article 100995. https://doi.org/10.1016/j.medj.2025.100995

Nagy, M., Gomes, T., Van Oerle, R., Hacking, T. M., Magdelijns, F. J. H., Henskens, Y. M. C., Reitsma, P., Short, G., Spronk, H. M. H., & Verhoef, D. (2026). Coagulation assays for assessing the bypassing of factor Xa direct oral anticoagulants using VMX-C001. Research and practice in thrombosis and haemostasis, 10(2), Article e103375. https://doi.org/10.1016/j.rpth.2026.103375

Magdelijns, F. J. H., de Jong, M. J., Winckers, K., Braeken, D. C. W., & Cate, H. T. (2026). Frail older patients and direct oral anticoagulants: trouble in paradise?Journal of Thrombosis and Haemostasis, 24(2), 781-783. https://doi.org/10.1016/j.jtha.2025.10.034

Biguzzi, E., Winckers, K., Hackeng, T. M., Rosendaal, F. R., & Vlieg, A. V. H. (2026). Recurrent venous thromboembolism: association with thrombin generation and d-dimer. Research and practice in thrombosis and haemostasis, 10(2), Article 103391. https://doi.org/10.1016/j.rpth.2026.103391

Kempers, E. K., Acampo-de Jong, M. J. J., ten Cate, H., De Caterina, R., & Kruip, M. J. H. A. (2026). Timeless therapeutics: cardiac indications for vitamin K antagonists in clinical practice. Heart. https://doi.org/10.1136/heartjnl-2024-324551

Iding, A. F. J., Hupperetz, R. D., Brans, R. J. B., ten Cate, H., van Twist, D. J. L., & ten Cate-Hoek, A. J. (2026). Additional oxerutin therapy to promote deep vein thrombus resolution (RESOLVE-DVT): a randomized controlled pilot trial. Journal of Thrombosis and Haemostasis, 24(2), 644-653. https://doi.org/10.1016/j.jtha.2025.10.018

de Jong, M. J., Brys, A. D. H., Braeken, D., Pisters, R., Janssen, D. J. A., Altintas, S., Robben, S. H. M., Nicolai, S., Eurlings, C., Zwietering, A., De Jonghe, M., Vaes, B., De Backer, T., Grymonprez, M., Joosten, H., ten Cate, H., Winckers, K., & Magdelijns, F. J. H. (2026). Healthcare professionals' perspectives on prescribing DOACs to frail older patients; the DOAC-FRAIL questionnaire. BMC Geriatrics, 26(1), Article 418. https://doi.org/10.1186/s12877-026-06972-3

Jaakonmäki, N., Helin, T., Szanto, T., Zedde, M., Sarkanen, T., Martinez-Majander, N., Sinisalo, J., Junttola, U., Redfors, P., von Sarnowski, B., Waje-Andreassen, U., Ylikotila, P., Yesilot, N., Ryliskiene, K., Tulkki, L., Amaya Pascasio, L., Licenik, R., Ferdinand, P., Gerdts, E., ... SECRETO Study Group (2026). Anti-beta2-glycoprotein I IgG antibodies are associated with early-onset cryptogenic ischemic stroke. European Stroke Journal, 11(1), Article 23969873251351207. https://doi.org/10.1177/23969873251351207

Visser, C., Kempers, E. K., Seelig, J., Chen, Q., Adriaansen, H. J., Beinema, M. J., ten Cate-Hoek, A., Faber, L. M., Klok, F. A., Leebeek, F. W. G., van de Leur, S. J. C. M., Nierman, M. C., Pisters, R., Schindhelm, R. K., Stork, A. D. M., Wiersma, N. M., De Caterina, R., Cannegieter, S. C., Hemels, M. E. W., ... Kruip, M. J. H. A. (2026). Anticoagulation Therapeutic Ranges and Clinical Outcomes in Patients with a Mechanical Heart Valve Treated with Vitamin K Antagonists-a Nationwide Linked-data Dutch Study. Thrombosis and Haemostasis. Advance online publication. https://doi.org/10.1055/a-2773-5810

D'alessandro, E., Scaf, B., Opacic, D., van Hunnik, A., Sobota, V., Kuiper, M., Viola, M., Hutschalik, T., Langione, M., Pioner, J. M., Munts, C., Simons, J., Winters, J., Isaacs, A., Heitmeier, S., Stoll, M., van Oerle, R., Ten Cate, H., Spronk, H. M. H., ... Schotten, U. (2026). Rivaroxaban Treatment Prevents Atrial Myocyte Hypertrophy in Goats with Persistent Atrial Fibrillation by Inhibition of Protease-Activated Receptor-1. Thrombosis and Haemostasis. Advance online publication. https://doi.org/10.1055/a-2761-6106

Denessen, E. J. S., Vroemen, W. H. M., Jansen, T. G. F., Henskens, Y. M. C., Bekers, O., & Mingels, A. M. A. (2026). The effect of anticoagulation medication on cardiac troponin T degradation: a proof of principle study. Journal of Laboratory and Precision Medicine, 11, Article 33. https://doi.org/10.21037/jlpm-2026-1-0013

Hupperetz, R. D., Iding, A. F. J., van Laanen, J., Brans, R., Notten, P., Asiong, J., Wikkeling, O. R. M., Vleming, L.-J., Jacobs, E. M. G., Koster, A., Wittens, C., ten Cate, H., & ten Cate-Hoek, A. J. (2026). Biomarkers in Relation to Patency, Popliteal Reflux, and Post-thrombotic Syndrome: A Subanalysis of the Ultrasound-accelerated Catheter-directed Thrombolysis versus Anticoagulation for the Prevention of Post-thrombotic Syndrome Trial. Thrombosis and Haemostasis. Advance online publication. https://doi.org/10.1055/a-2794-5116

Cate-Hoek, A. J. T., & Rocca, B. (2026). Glycoprotein IIb/IIIa Blockade: Ready to CELEBRATE a New Dawn?European Cardiology Review, 21, 1-2. Article e08. https://doi.org/10.15420/ecr.2025.98

Nieuwenstein, T., Stoffer, I. P., Hellenbrand, D. L. S., Mathot, R. A. A., van Pelt, L. J., Pequeriaux, N. C. V., van de Kerkhof, D., Kuijper, P. H. M., Zant, J. C., Garnier, D. A. J., Schindhelm, R. K., Hamer, H. M., van Duijnhoven, H. L. P., Bosman, M. C. J., Jeninga, E. H., de Kok, J. B., Schellings, M. W. M., Waals-Prinzen, L., Rijpma, S. R., ... Stroobants, A. K. (2026). Reagent-specific anti-Xa DOAC safety cutoffs can be established using multiple LMWH-calibrated anti-Xa assays. Clinical Chemistry and Laboratory Medicine. Advance online publication. https://doi.org/10.1515/cclm-2026-0026

Wu, Y., Van Dellen, F., Ten Cate, H., Henskens, Y., & Winckers, K. (2025). Challenges in diagnosing sticky platelet syndrome using light transmission aggregometry: a scoping review. Platelets, 36(1), Article 2560380. https://doi.org/10.1080/09537104.2025.2560380

Vicente-Steijn, R., Spiegelenberg, J., Rijpma, S. R., Henskens, Y. M. C., Leentjens, J., Ponjee, G., & Stroobants, A. (2025). A scoping review protocol on active drug monitoring of direct oral anticoagulants on vulnerable patient groups to detect potential adverse risks. Thrombosis Update, 21, Article 100223. https://doi.org/10.1016/j.tru.2025.100223

van der Horst, S. F. B., Chu, G., Seelig, J., Trinks-Roerdink, E. M., Voorhout, L., de Vries, T. A. C., van Alem, A. P., Beukema, R. J., Boersma, L. V. A., Brouwer, M. A., ten Cate, H., Faber, L. M., de Groot, J. R., Gu, Y. L., den Hartog, F. R., de Jong, J. S. S. G., de Jong, Y., Kirchhof, C. J. H. J., Kleijwegt, F. S., ... Huisman, M. V. (2025). Predicting clinically relevant bleeding in new-onset atrial fibrillation patients initiating oral anticoagulant therapy: External validation of the AF-BLEED score. Thrombosis Research, 256, Article 109533. https://doi.org/10.1016/j.thromres.2025.109533

Barakzie, A., van der Steen, W., Jansen, A. J. G., Roozenbeek, B., Donkel, S. J., van der Lugt, A., Lingsma, H., Dippel, D. W. J., Cate, H. T., de Maat, M. P. M., & CONTRAST Consortium (2025). Association of NETs Markers with Clinical and Radiological Outcomes in Patients with Acute Ischemic Stroke Undergoing Thrombectomy: Does Heparin Treatment Modify This?Translational Stroke Research, 16(6), 1985-1995. https://doi.org/10.1007/s12975-025-01362-0

Obino, G., Nieddu, G., Nagy, M., Ippel, H., Cubeddu, T., Spronk, H. M. H., Hackeng, T. M., Formato, M., Lepedda, A. J., & Moroni, L. (2025). Marine-derived sulfated polysaccharides enhance hemocompatibility and endothelialization of nanofibrous PCL for vascular graft applications. Cell Biomaterials, 1(10), Article 100155. https://doi.org/10.1016/j.celbio.2025.100155

Deltadahl, S., Gilbey, J., Van Laer, C., Boeckx, N., Leers, M. P. G., Freeman, T., Aiken, L., Farren, T., Smith, M., Zeina, M., MacDonald, S., Gleghorn, D., Rudd, J. H. F., Ouwehand, W. H., Amenga-Etego, L., Sarpong, K., Awandare, G. A., Trompeter, S., Gupta, R., ... BloodCounts! consortium (2025). Deep generative classification of blood cell morphology. Nature Machine Intelligence, 7(11), 1791-1803. https://doi.org/10.1038/s42256-025-01122-7

Stenger, W. J. E., den Uil, C. A., Rietdijk, W. J. R., Al Amri, I., Montero-Cabezas, J. M., Elzo Kraemer, C. V., van Mens, T. E., Meuwese, C. L., van Mieghem, N. M. D. A., Lauw, M. N., van den Toorn, L. M., Levolger, S., van de Luijtgaarden, K. M., Sprenger, R. A., van Dongen, J. M., Imani, F., Meuwissen, M., Kant, K. M., Aarts, R. A. H. M., ... Klok, F. A. (2025). Thrombectomy in high-risk pulmonary embolism – device versus thrombolysis: rationale and design of the TORPEDO-NL investigator-initiated, academically-sponsored, multicenter, open-label randomized controlled trial. Thrombosis Research, 255, Article 109420. https://doi.org/10.1016/j.thromres.2025.109420

D'Italia, G., Coenen, D. M., Lemmens, T. P., Brandts, L., Wielders, S. J. H., Nagy, M., Mourmans, S. G. J., Achten, A., Al-Abadi, A., Weerts, J., Aizpurua, A. B., van Empel, V., Schroen, B., & Cosemans, J. M. E. M. (2025). Immuno-haemostatic dysregulation in heart failure with preserved ejection fraction. Esc heart failure, 12(5), 3444-3460. https://doi.org/10.1002/ehf2.15361

van der Bie, J., Coleon, A., Visser, D., Bogers, W. M., den Dunnen, J., Spronk, H. M. H., Langermans, J. A. M., Willemen, H. L. D. M., De Melo, G. D., Middeldorp, J., & Stammes, M. A. (2025). Post Pandemic Problem, is there an animal model suitable to investigate PASC. npj Imaging, 3(1), Article 41. https://doi.org/10.1038/s44303-025-00101-2

Klein, D. O., Waardenburg, S. F., Janssen, E. B. N. J., Wintjens, M. S. J. N., Imkamp, M., Heemskerk, S. C. M., Birnie, E., Bonsel, G. J., Warlé, M. C., Jacobs, L. M. C., Hemmen, B., Verbunt, J., van Bussel, B. C. T., van Santen, S., Kietelaer, B. L. J. H., Jansen, G., Klok, F. A., de Kruif, M. D., Vernooy, K., ... CAPACITY-COVID collaborative consortium (2025). Two years and counting: a prospective cohort study on the scope and severity of post-COVID symptoms across diverse patient groups in the Netherlands-insights from the CORFU study. BMJ Open, 15(9), Article e093639. https://doi.org/10.1136/bmjopen-2024-093639

Wang, M., Taha, A., Nagy, M., Raben, J. D., van Noort, R., Volovici, V., Dammers, R., Duncker, D. J., Spronk, H., Ten Cate, H., Dippel, D., Bobi, J., & van Beusekom, H. M. M. (2025). Microvascular Occlusion and Postrecanalization Hyperperfusion in a Swine Model of Acute Ischemic Stroke. Journal of the American Heart Association, 14(18), Article e042663. https://doi.org/10.1161/JAHA.125.042663

Monard, A. L. L., Hellenbrand, D., Verhezen, P., Beckers, E. A. M., Henskens, Y. C. M., & Heubel-Moenen, F. C. J. I. (2025). tPA-ROTEM identifies hyperfibrinolytic profile in a significant proportion of patients with bleeding disorder of unknown cause (BDUC). Thrombosis Research, 253, Article 109404. https://doi.org/10.1016/j.thromres.2025.109404

Erdoes, G., Koster, A., & Cate, H. T. (2025). Not Only Drug Efficacy Counts! A Call for Adequately Powered Safety Trials. Journal of Cardiothoracic and Vascular Anesthesia, 39(9), 2542-2543. https://doi.org/10.1053/j.jvca.2025.05.025

Baaten, C. C. F. M. J., Wollenhaupt, J., Henning, T. M., Vondenhoff, S., Schröer, J. R., Stamellou, E., Saritas, T., Kurt, B., Boger, L., Antwerpen, A., Hermann, J., Nagy, M., Sternkopf, M., Buhl, E. M., Raffetseder, U., van der Meijden, P. E. J., Kuijpers, M. J. E., Spronk, H. M. H., Schunk, S. J., ... Noels, H. (2025). Impaired Secondary Platelet Response in Chronic Kidney Disease as a Consequence of Prior Platelet Activation. JACC: Basic to Translational Science, 10(9), Article 101355. https://doi.org/10.1016/j.jacbts.2025.101355

Vleeshouwers, K., Bastings, J. J. C., Brüggemann, R., de Jong, M. J., van den Boogaart, M., Poeze, M., van Es, N., Hanssen, N. M. J., Brouns, S., Magdelijns, F., & Spaetgens, B. (2025). Antithrombotic Therapy and Mortality Risk in Older Adults with Hip Fractures. Journal of the American Medical Directors Association, 26(8), Article 105690. https://doi.org/10.1016/j.jamda.2025.105690